CP, September 2018, Vol 10, No 9

Impulse-control disorders common in Parkinson’s patients taking dopamine agonists

Researchers find that after five years of follow-up, more than half of people taking dopamine agonists for management of Parkinson’s disease developed impulse-control disorders.…

Access to personalised cardiovascular risk information boosts lifestyle change

Research has shown that giving patients personalised information about their disease risk can motivate them to make lifestyle changes.…

Pembrolizumab effective in some men with advanced prostate cancer

A study of 258 men with otherwise untreatable prostate cancer shows that the rate of disease control or response lasting six months or more was 11%, with two patients showing complete response.…

Sleep disruption linked to atrial fibrillation risk

Sleep disruption is an important risk factor for developing atrial fibrillation, study results show.…